Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration

IMPORTANCE: Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness with several intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents available for its management such as aflibercept, bevacizumab, and ranibizumab. However, direct comparisons between the...

Descripción completa

Detalles Bibliográficos
Autores principales: Eng, Victor A., Rayess, Nadim, Nguyen, Huy V., Leng, Theodore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200004/
https://www.ncbi.nlm.nih.gov/pubmed/32369500
http://dx.doi.org/10.1371/journal.pone.0232353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200004/
https://www.ncbi.nlm.nih.gov/pubmed/32369500
http://dx.doi.org/10.1371/journal.pone.0232353

Ejemplares similares